Predicting treatment response to ketamine in treatment-resistant depression using auditory mismatch negativity: Study protocol.
PloS one January 1, 2024 Josh Martin, Fatemeh Gholamali Nezhad, Alice Rueda et al. 2 citations
Ketamine shows rapid antidepressant effects in major depressive disorder, including treatment-resistant depression, but many patients do not respond, and predicting who will benefit is difficult. This study will examine computational mechanisms behind changes in the auditory mismatch negativity response after intravenous ketamine, linking them to neural causes using a hierarchical Bayesian model and a neural mass model. Thirty patients with treatment-resistant depression will undergo EEG recordings during an auditory mismatch negativity task before three of four ketamine infusions, with depression, suicidality, and anxiety assessed throughout. The findings may improve understanding of treatment response and resistance, and model parameters could enable single-patient treatment predictions.